Log in to save to my catalogue

Analgesic characteristics of a newly developed α2δ ligand, mirogabalin, on inflammatory pain

Analgesic characteristics of a newly developed α2δ ligand, mirogabalin, on inflammatory pain

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8649095

Analgesic characteristics of a newly developed α2δ ligand, mirogabalin, on inflammatory pain

About this item

Full title

Analgesic characteristics of a newly developed α2δ ligand, mirogabalin, on inflammatory pain

Publisher

Los Angeles, CA: SAGE Publications

Journal title

Molecular pain, 2021-11, Vol.17, p.17448069211052167-17448069211052167

Language

English

Formats

Publication information

Publisher

Los Angeles, CA: SAGE Publications

More information

Scope and Contents

Contents

Mirogabalin is a novel α2δ ligand approved in Japan for the treatment of peripheral neuropathic pain. However, the sites of action of α2δ ligands to produce analgesic effects on inflammatory pain remain unclear. In this study, we investigated the analgesic effect and site of action of mirogabalin using the rat formalin test, an acute inflammatory p...

Alternative Titles

Full title

Analgesic characteristics of a newly developed α2δ ligand, mirogabalin, on inflammatory pain

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8649095

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8649095

Other Identifiers

ISSN

1744-8069

E-ISSN

1744-8069

DOI

10.1177/17448069211052167

How to access this item